SRXH

insider transactions

SRx Health Solutions, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Mar 16, 26

Kent Douglas Cunningham KEY

Chief Executive Officer

$78.8K

247.5K sh · $0.32

Own New
Grant·A
Mar 16, 26

Kent Douglas Cunningham KEY

Chief Executive Officer

$50.4K

63 sh · $800.00

Own New
Grant·A
Dec 3, 25

Kent Douglas Cunningham KEY

Chief Executive Officer

$78.0K

200.0K sh · $0.39

Own +44%
Grant·A
Dec 3, 25

Simon Alexander Malcolm Conway

Director

$245.7K

630.0K sh · $0.39

Own +308%
Grant·A
Sep 26, 25

Kent Douglas Cunningham KEY

Chief Executive Officer

$14.7K

44.5K sh · $0.33

Own +11%
Grant·A
Aug 25, 25

Kent Douglas Cunningham KEY

Chief Executive Officer

$93.4K

231.2K sh · $0.40

Own +129%
Grant·A
Aug 25, 25

Simon Alexander Malcolm Conway

Director

$61.7K

154.1K sh · $0.40

Own +304%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Mar 16, 2026	Kent Douglas Cunningham KEY	Chief Executive Officer	Grant A	247.5K	New	$0.32	$78.8K
Mar 16, 2026	Kent Douglas Cunningham KEY	Chief Executive Officer	Grant A	63	New	$800.00	$50.4K
Dec 3, 2025	Kent Douglas Cunningham KEY	Chief Executive Officer	Grant A	200.0K	+44%	$0.39	$78.0K
Dec 3, 2025	Simon Alexander Malcolm Conway	Director	Grant A	630.0K	+308%	$0.39	$245.7K
Sep 26, 2025	Kent Douglas Cunningham KEY	Chief Executive Officer	Grant A	44.5K	+11%	$0.33	$14.7K
Aug 25, 2025	Kent Douglas Cunningham KEY	Chief Executive Officer	Grant A	231.2K	+129%	$0.40	$93.4K
Aug 25, 2025	Simon Alexander Malcolm Conway	Director	Grant A	154.1K	+304%	$0.40	$61.7K

About SRXH insider trading

This page tracks insider transactions for SRx Health Solutions, Inc. (SRXH) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.